<DOC>
	<DOC>NCT02722993</DOC>
	<brief_summary>To assess the effect of a probiotic product, when co-administered with antibiotics, on gastrointestinal symptoms following antibiotic treatment in children.</brief_summary>
	<brief_title>Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Children at the age of 111 years that have been prescribed antibiotic treatment. Problems with loose stools during earlier antibiotic treatments. Children whose parents or legal caregivers have signed the informed consent to participate in the study. Chronic intestinal disease, immunodeficiency or immunosuppressive treatment. Chronic or acute diarrheal disease. Use of laxatives the week before inclusion in the study. Antibiotic treatment for the last four weeks before inclusion in the study. Intake of probiotic products for the last two weeks before inclusion in the study. Known hypersensitivity to any of the ingredients in the probiotic product or the placebo (potato starch Â± bacterial culture that may contain traces of soy). Patient requiring hospitalisation.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>